| Year |
Citation |
Score |
| 2017 |
Counsell JR, Asgarian Z, Meng J, Ferrer V, Vink CA, Howe SJ, Waddington SN, Thrasher AJ, Muntoni F, Morgan JE, Danos O. Lentiviral vectors can be used for full-length dystrophin gene therapy. Scientific Reports. 7: 79. PMID 28250438 DOI: 10.1038/S41598-017-00152-5 |
0.389 |
|
| 2016 |
Meng J, Counsell JR, Reza M, Laval SH, Danos O, Thrasher A, Lochmüller H, Muntoni F, Morgan JE. Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy. Scientific Reports. 6: 19750. PMID 26813695 DOI: 10.1038/Srep19750 |
0.331 |
|
| 2014 |
He C, Gouble A, Bourdel A, Manchev V, Poirot L, Paques F, Duchateau P, Edelman A, Danos O. Lentiviral protein delivery of meganucleases in human cells mediates gene targeting and alleviates toxicity. Gene Therapy. 21: 759-66. PMID 24919419 DOI: 10.1038/Gt.2014.51 |
0.38 |
|
| 2014 |
Tardieu M, Zérah M, Husson B, de Bournonville S, Deiva K, Adamsbaum C, Vincent F, Hocquemiller M, Broissand C, Furlan V, Ballabio A, Fraldi A, Crystal RG, Baugnon T, Roujeau T, ... ... Danos O, et al. Intracerebral administration of adeno-associated viral vector serotype rh.10 carrying human SGSH and SUMF1 cDNAs in children with mucopolysaccharidosis type IIIA disease: results of a phase I/II trial. Human Gene Therapy. 25: 506-16. PMID 24524415 DOI: 10.1089/Hum.2013.238 |
0.512 |
|
| 2014 |
van Til NP, Sarwari R, Visser TP, Hauer J, Lagresle-Peyrou C, van der Velden G, Malshetty V, Cortes P, Jollet A, Danos O, Cassani B, Zhang F, Thrasher AJ, Fontana E, Poliani PL, et al. Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome. The Journal of Allergy and Clinical Immunology. 133: 1116-23. PMID 24332219 DOI: 10.1016/J.Jaci.2013.10.009 |
0.386 |
|
| 2013 |
Brégnard C, Zamborlini A, Leduc M, Chafey P, Camoin L, Saïb A, Benichou S, Danos O, Basmaciogullari S. Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity. Journal of Virology. 87: 3729-40. PMID 23325686 DOI: 10.1128/Jvi.02477-12 |
0.32 |
|
| 2012 |
Eckenfelder A, Tordo J, Babbs A, Davies KE, Goyenvalle A, Danos O. The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery. Molecular Therapy. Nucleic Acids. 1: e31. PMID 23344083 DOI: 10.1038/Mtna.2012.24 |
0.341 |
|
| 2012 |
Brégnard C, Pacini G, Danos O, Basmaciogullari S. Suboptimal provirus expression explains apparent nonrandom cell coinfection with HIV-1. Journal of Virology. 86: 8810-20. PMID 22696639 DOI: 10.1128/Jvi.00831-12 |
0.323 |
|
| 2011 |
Gao G, Zhong L, Danos O. Exploiting natural diversity of AAV for the design of vectors with novel properties. Methods in Molecular Biology (Clifton, N.J.). 807: 93-118. PMID 22034027 DOI: 10.1007/978-1-61779-370-7_4 |
0.338 |
|
| 2011 |
Izmiryan A, Basmaciogullari S, Henry A, Paques F, Danos O. Efficient gene targeting mediated by a lentiviral vector-associated meganuclease. Nucleic Acids Research. 39: 7610-9. PMID 21715375 DOI: 10.1093/Nar/Gkr524 |
0.363 |
|
| 2011 |
Héron B, Mikaeloff Y, Froissart R, Caridade G, Maire I, Caillaud C, Levade T, Chabrol B, Feillet F, Ogier H, Valayannopoulos V, Michelakakis H, Zafeiriou D, Lavery L, Wraith E, ... Danos O, et al. Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. American Journal of Medical Genetics. Part A. 155: 58-68. PMID 21204211 DOI: 10.1002/Ajmg.A.33779 |
0.487 |
|
| 2011 |
Brégnard C, Danos O, Basmacioqullari S. Comparative proteomics of wild-type and nef-deleted HIV-1 particles Retrovirology. 8: P3. DOI: 10.1186/1742-4690-8-S2-P3 |
0.35 |
|
| 2010 |
Cohen-Haguenauer O, Creff N, Cruz P, Tunc C, Aïuti A, Baum C, Bosch F, Blomberg P, Cichutek K, Collins M, Danos O, Dehaut F, Federspiel M, Galun E, Garritsen H, et al. Relevance of an academic GMP Pan-European vector infra-structure (PEVI). Current Gene Therapy. 10: 414-22. PMID 21054249 DOI: 10.2174/156652310793797702 |
0.32 |
|
| 2010 |
Danos O, Davies K, Lehn P, Mulligan R. The ARRIVE guidelines, a welcome improvement to standards for reporting animal research. The Journal of Gene Medicine. 12: 559-60. PMID 20603891 DOI: 10.1002/Jgm.1472 |
0.44 |
|
| 2009 |
Denard J, Rundwasser S, Laroudie N, Gonnet F, Naldini L, Radrizzani M, Galy A, Merten OW, Danos O, Svinartchouk F. Quantitative proteomic analysis of lentiviral vectors using 2-DE. Proteomics. 9: 3666-76. PMID 19639585 DOI: 10.1002/Pmic.200800747 |
0.334 |
|
| 2009 |
Leclerc X, Danos O, Scherman D, Kichler A. A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repair. Bmc Biotechnology. 9: 35. PMID 19379497 DOI: 10.1186/1472-6750-9-35 |
0.333 |
|
| 2009 |
Lagache T, Danos O, Holcman D. Modeling The Endosomal Stage Of Viral Infection Biophysical Journal. 96: 3-7. DOI: 10.1016/J.Bpj.2008.12.1532 |
0.327 |
|
| 2008 |
Danos O. AAV vectors for RNA-based modulation of gene expression. Gene Therapy. 15: 864-9. PMID 18418414 DOI: 10.1038/Gt.2008.69 |
0.306 |
|
| 2008 |
Takeuchi Y, Myers R, Danos O. Recombination and population mosaic of a multifunctional viral gene, adeno-associated virus cap. Plos One. 3: e1634. PMID 18286191 DOI: 10.1371/Journal.Pone.0001634 |
0.345 |
|
| 2008 |
Lorain S, Gross DA, Goyenvalle A, Danos O, Davoust J, Garcia L. Transient immunomodulation allows repeated injections of AAV1 and correction of muscular dystrophy in multiple muscles. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 541-7. PMID 18180780 DOI: 10.1038/Sj.Mt.6300377 |
0.31 |
|
| 2007 |
Charrier S, Dupré L, Scaramuzza S, Jeanson-Leh L, Blundell MP, Danos O, Cattaneo F, Aiuti A, Eckenberg R, Thrasher AJ, Roncarolo MG, Galy A. Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients. Gene Therapy. 14: 415-28. PMID 17051251 DOI: 10.1038/sj.gt.3302863 |
0.309 |
|
| 2006 |
Olivier A, Jeanson-Leh L, Bouma G, Compagno D, Blondeau J, Seye K, Charrier S, Burns S, Thrasher AJ, Danos O, Vainchenker W, Galy A. A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 729-37. PMID 16360341 DOI: 10.1016/J.Ymthe.2005.11.003 |
0.373 |
|
| 2003 |
Coeytaux E, Coulaud D, Le Cam E, Danos O, Kichler A. The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. The Journal of Biological Chemistry. 278: 18110-6. PMID 12639957 DOI: 10.1074/Jbc.M300248200 |
0.317 |
|
| 2000 |
Heard J, Danos O, Peschanski M. Réflexions sur l'avenir de la thérapie génique. MéDecine/Sciences. 16: 1305. DOI: 10.4267/10608/1582 |
0.452 |
|
| 2000 |
Heard JM, Danos O, Peschanski M. Where does gene therapy go? | Reflexions sur l'avenir de la therapie genique Medecine/Sciences. 16: 1305-1309. |
0.515 |
|
| 1998 |
Rendahl KG, Leff SE, Otten GR, Spratt SK, Bohl D, Van Roey M, Donahue BA, Cohen LK, Mandel RJ, Danos O, Snyder RO. Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nature Biotechnology. 16: 757-61. PMID 9702775 DOI: 10.1038/Nbt0898-757 |
0.371 |
|
| 1998 |
Battini JL, Danos O, Heard JM. Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor. Journal of Virology. 72: 428-35. PMID 9420242 |
0.506 |
|
| 1997 |
Ferry N, Branchereau S, Heard JM, Danos O. In situ retrovirus-mediated gene transfer into the liver. Methods in Molecular Medicine. 7: 195-204. PMID 24493427 DOI: 10.1385/0-89603-484-4:195 |
0.596 |
|
| 1997 |
Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genetics. 16: 270-6. PMID 9207793 DOI: 10.1038/Ng0797-270 |
0.385 |
|
| 1996 |
Moullier P, Salvetti A, Bohl D, Danos O, Heard JM. [Gene therapy in lysosomal diseases]. Comptes Rendus Des SéAnces De La SociéTé De Biologie Et De Ses Filiales. 190: 45-51. PMID 8881268 |
0.562 |
|
| 1996 |
Naffakh N, Pinset C, Montarras D, Li Z, Paulin D, Danos O, Heard JM. Long-term secretion of therapeutic proteins from genetically modified skeletal muscles. Human Gene Therapy. 7: 11-21. PMID 8825864 DOI: 10.1089/hum.1996.7.1-11 |
0.554 |
|
| 1996 |
Moullier P, Salvetti A, Bohl D, Danos O, Heard JM. [Gene therapy of lysosomal diseases]. Archives De PéDiatrie : Organe Officiel De La SociéTe FrançAise De PéDiatrie. 3: 65s-68s. PMID 8795971 DOI: 10.1016/0929-693X(96)85996-3 |
0.676 |
|
| 1996 |
Champseix C, Maréchal V, Khazaal I, Schwartz O, Fournier S, Schlegel N, Dranoff G, Danos O, Blot P, Vilmer E, Heard JM, Péault B, Lehn P. A cell surface marker gene transferred with a retroviral vector into CD34+ cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus. Blood. 88: 107-13. PMID 8704164 |
0.582 |
|
| 1996 |
Battini JL, Rodrigues P, Müller R, Danos O, Heard JM. Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. Journal of Virology. 70: 4387-93. PMID 8676462 |
0.527 |
|
| 1996 |
Lavau C, Heard JM, Danos O, Dejean A. Retroviral vectors for the transduction of the PML-RARalpha fusion product of acute promyelocytic leukemia. Experimental Hematology. 24: 544-51. PMID 8608805 |
0.549 |
|
| 1996 |
Hacein-Bey H, Cavazzana-Calvo M, Le Deist F, Dautry-Varsat A, Hivroz C, Rivière I, Danos O, Heard JM, Sugamura K, Fischer A, De Saint Basile G. gamma-c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function. Blood. 87: 3108-16. PMID 8605324 |
0.531 |
|
| 1996 |
Mouiller P, Salvetti A, Bohl D, Danos O, Heard JM. Thérapie génique des maladies lysosomales Archives De Pediatrie. 3: 65s-68s. |
0.455 |
|
| 1995 |
Naffakh N, Moullier P, Salvetti A, Bohl D, Danos O, Heard JM. Delivery of therapeutic proteins from genetically-modified cells. Restorative Neurology and Neuroscience. 8: 67-9. PMID 21551810 DOI: 10.3233/Rnn-1995-81216 |
0.681 |
|
| 1995 |
Danos O, Heard JM. Mucopolysaccharidosis. Molecular and Cell Biology of Human Diseases Series. 5: 350-67. PMID 9532574 |
0.476 |
|
| 1995 |
Carreau M, Quilliet X, Eveno E, Salvetti A, Danos O, Heard JM, Mezzina M, Sarasin A. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients. Human Gene Therapy. 6: 1307-15. PMID 8590735 DOI: 10.1089/hum.1995.6.10-1307 |
0.529 |
|
| 1995 |
Salvetti A, Moullier P, Cornet V, Brooks D, Hopwood JJ, Danos O, Heard JM. In vivo delivery of human alpha-L-iduronidase in mice implanted with neo-organs. Human Gene Therapy. 6: 1153-9. PMID 8527473 DOI: 10.1089/Hum.1995.6.9-1153 |
0.695 |
|
| 1995 |
Schwartz O, Dautry-Varsat A, Goud B, Maréchal V, Subtil A, Heard JM, Danos O. Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. Journal of Virology. 69: 528-33. PMID 7983750 DOI: 10.1128/Jvi.69.1.528-533.1995 |
0.557 |
|
| 1995 |
Cartier N, Lopez J, Moullier P, Rocchiccioli F, Rolland MO, Jorge P, Mosser J, Mandel JL, Bougnères PF, Danos O, Aubourg P. Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts Proceedings of the National Academy of Sciences of the United States of America. 92: 1674-1678. PMID 7878038 DOI: 10.1073/Pnas.92.5.1674 |
0.543 |
|
| 1995 |
Battini JL, Danos O, Heard JM. Receptor-binding domain of murine leukemia virus envelope glycoproteins. Journal of Virology. 69: 713-9. PMID 7815534 |
0.542 |
|
| 1995 |
Salvetti A, Heard JM, Danos O. Gene therapy of lysosomal storage disorders. British Medical Bulletin. 51: 106-22. PMID 7767637 |
0.561 |
|
| 1995 |
Naffakh N, Henri A, Villeval JL, Rouyer-Fessard P, Moullier P, Blumenfeld N, Danos O, Vainchenker W, Heard JM, Beuzard Y. Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts. Proceedings of the National Academy of Sciences of the United States of America. 92: 3194-8. PMID 7724539 |
0.56 |
|
| 1995 |
Valere T, Bohl D, Klatzmann D, Danos O, Sonigo P, Heard JM. Continuous secretion of human soluble CD4 in mice transplanted with genetically modified cells. Gene Therapy. 2: 197-202. PMID 7614250 |
0.566 |
|
| 1995 |
Moullier P, Bohl D, Cardoso J, Heard JM, Danos O. Long-term delivery of a lysosomal enzyme by genetically modified fibroblasts in dogs. Nature Medicine. 1: 353-7. PMID 7585066 DOI: 10.1038/Nm0495-353 |
0.676 |
|
| 1995 |
Schwartz O, Maréchal V, Danos O, Heard JM. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. Journal of Virology. 69: 4053-9. PMID 7539505 DOI: 10.1128/Jvi.69.7.4053-4059.1995 |
0.591 |
|
| 1995 |
Naffakh N, Moullier P, Salvetti A, Bohl D, Danos O, Heard JM. Delivery of therapeutic proteins from genetically-modified cells Restorative Neurology and Neuroscience. 8: 67-69. |
0.54 |
|
| 1994 |
Valsesia-Wittmann S, Drynda A, Deléage G, Aumailley M, Heard JM, Danos O, Verdier G, Cosset FL. Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. Journal of Virology. 68: 4609-19. PMID 8207835 DOI: 10.1128/Jvi.68.7.4609-4619.1994 |
0.543 |
|
| 1994 |
Naffakh N, Bohl D, Salvetti A, Moullier P, Danos O, Heard JM. Gene therapy for lysosomal disorders. Nouvelle Revue FrançAise D'HéMatologie. 36: S11-6. PMID 8177709 |
0.602 |
|
| 1994 |
Battini JL, Kayman SC, Pinter A, Heard JM, Danos O. Role of N-linked glycosylation in the activity of the Friend murine leukemia virus SU protein receptor-binding domain. Virology. 202: 496-9. PMID 8009864 DOI: 10.1006/Viro.1994.1369 |
0.502 |
|
| 1994 |
Schwartz O, Alizon M, Heard JM, Danos O. Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. Virology. 198: 360-5. PMID 7903129 DOI: 10.1006/Viro.1994.1042 |
0.581 |
|
| 1993 |
Schwartz O, Rivière Y, Heard JM, Danos O. Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef. Journal of Virology. 67: 3274-80. PMID 8497051 DOI: 10.1128/Jvi.67.6.3274-3280.1993 |
0.596 |
|
| 1993 |
Naffakh N, Le Gall S, Danos O, Heard JM, Cournot G, Motoyoshi K, Vilmer E. Macrophage colony-stimulating factor: serum levels and cDNA structure in malignant osteopetrosis. Blood. 81: 2817-8. PMID 8490189 DOI: 10.1182/Blood.V81.10.2817.2817 |
0.508 |
|
| 1993 |
Cardoso JE, Branchereau S, Jeyaraj PR, Houssin D, Danos O, Heard JM. In situ retrovirus-mediated gene transfer into dog liver. Human Gene Therapy. 4: 411-8. PMID 8399488 DOI: 10.1089/hum.1993.4.4-411 |
0.546 |
|
| 1993 |
Moullier P, Maréchal V, Danos O, Heard JM. Continuous systemic secretion of a lysosomal enzyme by genetically modified mouse skin fibroblasts. Transplantation. 56: 427-32. PMID 8356601 DOI: 10.1097/00007890-199308000-00034 |
0.695 |
|
| 1993 |
Maréchal V, Naffakh N, Danos O, Heard JM. Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cells. Blood. 82: 1358-65. PMID 8353294 DOI: 10.1182/Blood.V82.4.1358.Bloodjournal8241358 |
0.615 |
|
| 1993 |
Moullier P, Bohl D, Heard JM, Danos O. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nature Genetics. 4: 154-9. PMID 8348154 DOI: 10.1038/Ng0693-154 |
0.699 |
|
| 1993 |
Naffakh N, Pinset C, Montarras D, Pastoret C, Danos O, Heard JM. Transplantation of adult-derived myoblasts in mice following gene transfer. Neuromuscular Disorders : Nmd. 3: 413-7. PMID 8186684 DOI: 10.1016/0960-8966(93)90087-Z |
0.6 |
|
| 1993 |
Houssin D, Danos O, Heard JM. [The liver and gene therapy. Experimental or revolutionary procedure?]. La Revue Du Praticien. 43: 2380-2. PMID 8128159 |
0.527 |
|
| 1993 |
Branchereau S, Ferry N, Myara A, Sato H, Kowai O, Trivin F, Houssin D, Danos O, Heard J. Correction of bilirubin glucuronyl transferase in Gunn rats by gene transfer in the liver using retroviral vectors | Correction du déficit en bilirubine glucuronyl-transférase chez le rat Gunn par transfert de gène dans le foie au moyen de vecteurs rétroviraux Chirurgie Paris. 119: 642-648. PMID 7729182 |
0.544 |
|
| 1993 |
Danos O, Heard JM. Strategies and models for gene therapy | STRATEGIES ET MODELES POUR LA THERAPIE GENIQUE Annales De L'Institut Pasteur/Actualites. 4: 89-99. |
0.51 |
|
| 1993 |
Branchereau S, Ferry N, Myara A, Sato H, Kowai O, Trivin F, Houssin D, Danos O, Heard J. Correction of bilirubin glucuronyl transferase deficiency in the Guinn rat with gene transfer into the liver via retrovirus vectors | CORRECTION DU DEFICIT EN BILIRUBINE GLUCURONYL-TRANSFERASE CHEZ LE RAT GUNN PAR TRANSFERT DE GENE DANS LE FOIE AU MOYEN DE VECTEURS RETROVIRAUX Chirurgie - Memoires De L'Academie De Chirurgie. 119: 642-648. |
0.527 |
|
| 1992 |
Lubetzki C, Goujet-Zalc C, Demerens C, Danos O, Zalc B. Clonal segregation of oligodendrocytes and astrocytes during in vitro differentiation of glial progenitor cells Glia. 6: 289-300. PMID 1464461 DOI: 10.1002/Glia.440060407 |
0.315 |
|
| 1992 |
Schwartz O, Arenzana-Seisdedos F, Heard JM, Danos O. Activation pathways and human immunodeficiency virus type 1 replication are not altered in CD4+ T cells expressing the nef protein. Aids Research and Human Retroviruses. 8: 545-51. PMID 1355346 DOI: 10.1089/Aid.1992.8.545 |
0.544 |
|
| 1991 |
Danos O. Construction of Retro viral Packaging Cell Lines. Methods of Molecular Biology. 8: 17-27. PMID 21390697 DOI: 10.1385/0-89603-191-8:17 |
0.343 |
|
| 1990 |
Wilson JM, Danos O, Grossman M, Raulet DH, Mulligan RC. Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 87: 439-43. PMID 2296599 DOI: 10.1073/Pnas.87.1.439 |
0.562 |
|
| 1990 |
Lubetzki C, Goujet-Zalc C, Evrard C, Danos O, Rouget P, Zalc B. Gene transfer of rat mature oligodendrocytes and glial progenitor cells with the LacZ gene Annals of the New York Academy of Sciences. 605: 66-70. PMID 2125184 DOI: 10.1111/J.1749-6632.1990.Tb42381.X |
0.328 |
|
| 1988 |
Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proceedings of the National Academy of Sciences of the United States of America. 85: 6460-4. PMID 3413107 DOI: 10.1073/Pnas.85.17.6460 |
0.547 |
|
| 1988 |
Dostatni N, Yaniv M, Danos O, Mulligan RC. Use of retroviral vectors for mapping of splice sites in cottontail rabbit papillomavirus. The Journal of General Virology. 69: 3093-100. PMID 2848927 DOI: 10.1099/0022-1317-69-12-3093 |
0.515 |
|
| 1986 |
Danos O, Mulligan RC, Yaniv M. Production of spliced DNA copies of the cottontail rabbit papillomavirus genome in a retroviral vector. Ciba Foundation Symposium. 120: 68-82. PMID 3013527 |
0.453 |
|
| 1985 |
Wain-Hobson S, Sonigo P, Danos O, Cole S, Alizon M. Nucleotide sequence of the AIDS virus, LAV Cell. 40: 9-17. PMID 2981635 DOI: 10.1016/0092-8674(85)90303-4 |
0.313 |
|
| 1983 |
Stragier P, Danos O, Patte JC. Regulation of diaminopimelate decarboxylase synthesis in Escherichia coli. II. Nucleotide sequence of the lysA gene and its regulatory region Journal of Molecular Biology. 168: 321-331. PMID 6350601 DOI: 10.1016/S0022-2836(83)80021-7 |
0.317 |
|
| Show low-probability matches. |